After the 3 month blinding phase, all patients received DBS. “Seizure rates continued to improve in the open-label phase over time; seizure rates decreased by 56% after 2 years of treatment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback